Algo version: 0.98b
RYZB is listed at the NASDAQ Exchange
RYZB [RYZB]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is RYZB stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for RayzeBio, Inc. Common 10 years ago, but if you had invested on Friday 15th of September 2023 when the price was $24.00, you would have made a profit of $38.49 per share or 160.38%

Yes, the average daily trading liquidity for RayzeBio, Inc. Common is $25.87 million. You should therefore be able to get in and out of your positions relatively fast.

RayzeBio, Inc. Common has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for RayzeBio, Inc. Common to be medium [0.6 out of 1]